VenoStent
PrivateLast Round
Seed Round
May 1, 2026
Total Funding Raised
$27.74M
Momentum Score
25 /100
Company Overview
VenoStent is a biomedical engineering company that develops innovative shape-memory polymer technology to enhance the quality and longevity of life for dialysis patients by improving arteriovenous fistula usability and durability.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VenoStent Comps
Public and private peers based on sector, stage, and business model.
VenoStent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 1, 2026 | ||||
| Grant | Jun 27, 2024 | ||||
| Series A Extension | Jun 27, 2024 | ||||
| Series A | Aug 1, 2023 | ||||
| Seed | Feb 23, 2021 | ||||
SAFE | Jun 24, 2020 |
Key People
Founding team and executive leadership
VenoStent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Growth Capital | Series A, Series A Extension |
| IAG Capital Partners | Seed, Series A, Series A Extension |
| NIH RADx | Grant |
| TMC Venture Fund | Series A |
| Creative Ventures | Series A, Seed |
| SNR | Series A |
| Norwest Venture Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
$10M raised in Seed Round.
- Feb 23, 2021
Raised $2.3M led by Creative Ventures.
VenoStent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VenoStent's valuation, stock price, and market status.
